Emergent BioSolutions (EBS) Current Taxes (2012 - 2026)

Emergent BioSolutions (EBS) posted quarterly Current Taxes of $7.2 million for Q1 2026, up 5.88% quarter-over-quarter from $6.8 million in Q4 2025.

Emergent BioSolutions (EBS) Current Taxes (2012 - 2026) Analysis & Trends

Emergent BioSolutions' Current Taxes history runs 6 years deep, the most recent figure standing at $7.2 million for Q1 2026.

In Q1 2026, Current Taxes changed N/A year-over-year to $7.2 million; the TTM figure through Mar 2026 stood at $7.2 million (changed N/A YoY), while the FY2025 annual figure was $6.8 million, up 17.24% from the prior year.
Current Taxes for Q1 2026 stood at $7.2 million, up from $6.8 million in the prior quarter.
The five-year high for Current Taxes was $7.2 million in Q1 2026, with the low at $5.8 million in Q4 2024.
The 3-year median for Current Taxes is $6.8 million (2025), against an average of $6.6 million.
Peak annual rise in Current Taxes reached 17.24% in 2025, while the deepest fall reached 17.24% in 2025.
Emergent BioSolutions' Current Taxes stood at $5.8 million in 2024, then grew by 17.24% to $6.8 million in 2025, then advanced by 5.88% to $7.2 million in 2026.
Business Quant data shows EBS's Current Taxes at $7.2 million in Q1 2026, $6.8 million in Q4 2025, and $5.8 million in Q4 2024.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Current Taxes (Qtr)
1	Haleon	43.83 Bn	42.86 Bn	-	-355.54 Mn
2	Teva Pharmaceutical Industries	42.87 Bn	39.22 Bn	2.15 Bn	-
3	Zoetis	31.41 Bn	29.73 Bn	1.05 Bn	138.00 Mn
4	Takeda Pharmaceutical	28.55 Bn	22.75 Bn	5.10 Bn	739.89 Mn
5	United Therapeutics	22.08 Bn	19.42 Bn	683.80 Mn	-
6	Viatris	18.73 Bn	17.84 Bn	1.46 Bn	-
7	Neurocrine Biosciences	15.44 Bn	15.05 Bn	935.80 Mn	-
8	Elanco Animal Health	11.75 Bn	11.22 Bn	798.00 Mn	-
9	Dr Reddys Laboratories	10.11 Bn	9.94 Bn	-	46.00 Mn
10	Emergent BioSolutions	251.81 Mn	110.91 Mn	137.20 Mn	4.40 Mn

Download Data